CHMP recommendation for the authorisation of Paxlovid

Dear Members and Affiliated Societies, 

Please find a warning message by EMA drawing our attention to the potential drug-drug interactions with ritonavir contained in Paxlovid in this DOCUMENT

Yours faithfully,

_________________________________
Prof. Pierre Marquet, MD, PhD
President of EACPT (European Association of Clinical Pharmacology and Therapeutics)

Leave a Comment